Remarkably, Pax4 expression levels also increase in the STZ mouse model of diabetes [40], and in vivo ectopic overexpression of this factor enhances β-cell resistance to STZ [35], as well as against an autoimmune attack in a mouse model of experimental autoimmune diabetes [41]. Here, PAX4 is linked to diabetes mellitus.